Among these, PIK3R1 mutations were found in nearly 10% of GBM incidences, specifically impacting the PI3K/protein kinase b (AKT)/mTOR pathway which mediates cancer cell growth, survival and DNA repair in response to DNA damage. This evidence concerns the gene AKT1 and glioblastoma.